世界のメタボロミクスバイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metabolomics Biomarker Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3718 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、メタボロミクスバイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タンパク質マーカー、核酸マーカー）、用途別市場規模（毒物学的研究、薬物検査、癌、心血管障害、神経障害、先天性代謝異常症）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・メタボロミクスバイオマーカーの市場動向 ・企業の競争状況、市場シェア ・メタボロミクスバイオマーカーの種類別市場規模（タンパク質マーカー、核酸マーカー） ・メタボロミクスバイオマーカーの用途別市場規模（毒物学的研究、薬物検査、癌、心血管障害、神経障害、先天性代謝異常症） ・メタボロミクスバイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・メタボロミクスバイオマーカーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・メタボロミクスバイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・メタボロミクスバイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・メタボロミクスバイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biocrates Life Sciences、Biomark Diagnostics、Chenomx、Creative Proteomics、Evotec、Human Metabolome Technologies、Merck、Metabolomic Diagnostics、Metabolon、Ovid Therapeutics） ・結論

Market Analysis and Insights: Global Metabolomics Biomarker Market
The global Metabolomics Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metabolomics Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metabolomics Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metabolomics Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metabolomics Biomarker market.

Global Metabolomics Biomarker Scope and Market Size
Metabolomics Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metabolomics Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Protein Marker
Nucleic Acid Marker

Segment by Application
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biocrates Life Sciences
Biomark Diagnostics
Chenomx
Creative Proteomics
Evotec
Human Metabolome Technologies
Merck
Metabolomic Diagnostics
Metabolon

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolomics Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Protein Marker
1.2.3 Nucleic Acid Marker
1.3 Market by Application
1.3.1 Global Metabolomics Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Toxicological studies
1.3.3 Drug testing
1.3.4 Cancer
1.3.5 Cardiovascular disorders
1.3.6 Neurological disorders
1.3.7 Inborn errors of metabolism
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metabolomics Biomarker Market Perspective (2016-2027)
2.2 Metabolomics Biomarker Growth Trends by Regions
2.2.1 Metabolomics Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metabolomics Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Metabolomics Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Metabolomics Biomarker Industry Dynamic
2.3.1 Metabolomics Biomarker Market Trends
2.3.2 Metabolomics Biomarker Market Drivers
2.3.3 Metabolomics Biomarker Market Challenges
2.3.4 Metabolomics Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metabolomics Biomarker Players by Revenue
3.1.1 Global Top Metabolomics Biomarker Players by Revenue (2016-2021)
3.1.2 Global Metabolomics Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Metabolomics Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metabolomics Biomarker Revenue
3.4 Global Metabolomics Biomarker Market Concentration Ratio
3.4.1 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Biomarker Revenue in 2020
3.5 Metabolomics Biomarker Key Players Head office and Area Served
3.6 Key Players Metabolomics Biomarker Product Solution and Service
3.7 Date of Enter into Metabolomics Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolomics Biomarker Breakdown Data by Type
4.1 Global Metabolomics Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Metabolomics Biomarker Forecasted Market Size by Type (2022-2027)

5 Metabolomics Biomarker Breakdown Data by Application
5.1 Global Metabolomics Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Metabolomics Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metabolomics Biomarker Market Size (2016-2027)
6.2 North America Metabolomics Biomarker Market Size by Type
6.2.1 North America Metabolomics Biomarker Market Size by Type (2016-2021)
6.2.2 North America Metabolomics Biomarker Market Size by Type (2022-2027)
6.2.3 North America Metabolomics Biomarker Market Size by Type (2016-2027)
6.3 North America Metabolomics Biomarker Market Size by Application
6.3.1 North America Metabolomics Biomarker Market Size by Application (2016-2021)
6.3.2 North America Metabolomics Biomarker Market Size by Application (2022-2027)
6.3.3 North America Metabolomics Biomarker Market Size by Application (2016-2027)
6.4 North America Metabolomics Biomarker Market Size by Country
6.4.1 North America Metabolomics Biomarker Market Size by Country (2016-2021)
6.4.2 North America Metabolomics Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Metabolomics Biomarker Market Size (2016-2027)
7.2 Europe Metabolomics Biomarker Market Size by Type
7.2.1 Europe Metabolomics Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Metabolomics Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Metabolomics Biomarker Market Size by Type (2016-2027)
7.3 Europe Metabolomics Biomarker Market Size by Application
7.3.1 Europe Metabolomics Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Metabolomics Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Metabolomics Biomarker Market Size by Application (2016-2027)
7.4 Europe Metabolomics Biomarker Market Size by Country
7.4.1 Europe Metabolomics Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Metabolomics Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metabolomics Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Metabolomics Biomarker Market Size by Type
8.2.1 Asia-Pacific Metabolomics Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metabolomics Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metabolomics Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Metabolomics Biomarker Market Size by Application
8.3.1 Asia-Pacific Metabolomics Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metabolomics Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metabolomics Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Metabolomics Biomarker Market Size by Region
8.4.1 Asia-Pacific Metabolomics Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metabolomics Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metabolomics Biomarker Market Size (2016-2027)
9.2 Latin America Metabolomics Biomarker Market Size by Type
9.2.1 Latin America Metabolomics Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Metabolomics Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Metabolomics Biomarker Market Size by Type (2016-2027)
9.3 Latin America Metabolomics Biomarker Market Size by Application
9.3.1 Latin America Metabolomics Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Metabolomics Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Metabolomics Biomarker Market Size by Application (2016-2027)
9.4 Latin America Metabolomics Biomarker Market Size by Country
9.4.1 Latin America Metabolomics Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Metabolomics Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metabolomics Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Metabolomics Biomarker Market Size by Type
10.2.1 Middle East & Africa Metabolomics Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metabolomics Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metabolomics Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Metabolomics Biomarker Market Size by Application
10.3.1 Middle East & Africa Metabolomics Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metabolomics Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metabolomics Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Metabolomics Biomarker Market Size by Country
10.4.1 Middle East & Africa Metabolomics Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metabolomics Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biocrates Life Sciences
11.1.1 Biocrates Life Sciences Company Details
11.1.2 Biocrates Life Sciences Business Overview
11.1.3 Biocrates Life Sciences Metabolomics Biomarker Introduction
11.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2016-2021)
11.1.5 Biocrates Life Sciences Recent Development
11.2 Biomark Diagnostics
11.2.1 Biomark Diagnostics Company Details
11.2.2 Biomark Diagnostics Business Overview
11.2.3 Biomark Diagnostics Metabolomics Biomarker Introduction
11.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2016-2021)
11.2.5 Biomark Diagnostics Recent Development
11.3 Chenomx
11.3.1 Chenomx Company Details
11.3.2 Chenomx Business Overview
11.3.3 Chenomx Metabolomics Biomarker Introduction
11.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2016-2021)
11.3.5 Chenomx Recent Development
11.4 Creative Proteomics
11.4.1 Creative Proteomics Company Details
11.4.2 Creative Proteomics Business Overview
11.4.3 Creative Proteomics Metabolomics Biomarker Introduction
11.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2016-2021)
11.4.5 Creative Proteomics Recent Development
11.5 Evotec
11.5.1 Evotec Company Details
11.5.2 Evotec Business Overview
11.5.3 Evotec Metabolomics Biomarker Introduction
11.5.4 Evotec Revenue in Metabolomics Biomarker Business (2016-2021)
11.5.5 Evotec Recent Development
11.6 Human Metabolome Technologies
11.6.1 Human Metabolome Technologies Company Details
11.6.2 Human Metabolome Technologies Business Overview
11.6.3 Human Metabolome Technologies Metabolomics Biomarker Introduction
11.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2016-2021)
11.6.5 Human Metabolome Technologies Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Metabolomics Biomarker Introduction
11.7.4 Merck Revenue in Metabolomics Biomarker Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Metabolomic Diagnostics
11.8.1 Metabolomic Diagnostics Company Details
11.8.2 Metabolomic Diagnostics Business Overview
11.8.3 Metabolomic Diagnostics Metabolomics Biomarker Introduction
11.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2016-2021)
11.8.5 Metabolomic Diagnostics Recent Development
11.9 Metabolon
11.9.1 Metabolon Company Details
11.9.2 Metabolon Business Overview
11.9.3 Metabolon Metabolomics Biomarker Introduction
11.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2016-2021)
11.9.5 Metabolon Recent Development
11.10 Ovid Therapeutics
11.10.1 Ovid Therapeutics Company Details
11.10.2 Ovid Therapeutics Business Overview
11.10.3 Ovid Therapeutics Metabolomics Biomarker Introduction
11.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2016-2021)
11.10.5 Ovid Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metabolomics Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Protein Marker
Table 3. Key Players of Nucleic Acid Marker
Table 4. Global Metabolomics Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Metabolomics Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metabolomics Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Metabolomics Biomarker Market Share by Regions (2016-2021)
Table 8. Global Metabolomics Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Metabolomics Biomarker Market Share by Regions (2022-2027)
Table 10. Metabolomics Biomarker Market Trends
Table 11. Metabolomics Biomarker Market Drivers
Table 12. Metabolomics Biomarker Market Challenges
Table 13. Metabolomics Biomarker Market Restraints
Table 14. Global Metabolomics Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Metabolomics Biomarker Market Share by Players (2016-2021)
Table 16. Global Top Metabolomics Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolomics Biomarker as of 2020)
Table 17. Ranking of Global Top Metabolomics Biomarker Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Metabolomics Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metabolomics Biomarker Product Solution and Service
Table 21. Date of Enter into Metabolomics Biomarker Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metabolomics Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Metabolomics Biomarker Revenue Market Share by Type (2016-2021)
Table 25. Global Metabolomics Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Metabolomics Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Metabolomics Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Metabolomics Biomarker Revenue Market Share by Application (2016-2021)
Table 29. Global Metabolomics Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Metabolomics Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Metabolomics Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Metabolomics Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Metabolomics Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Metabolomics Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Metabolomics Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Metabolomics Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Metabolomics Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Metabolomics Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Metabolomics Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Metabolomics Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Metabolomics Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Metabolomics Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Metabolomics Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Metabolomics Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Metabolomics Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Metabolomics Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Metabolomics Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Metabolomics Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Metabolomics Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Metabolomics Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Metabolomics Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Metabolomics Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Metabolomics Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Metabolomics Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Metabolomics Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Metabolomics Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Metabolomics Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Metabolomics Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Metabolomics Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Metabolomics Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biocrates Life Sciences Company Details
Table 62. Biocrates Life Sciences Business Overview
Table 63. Biocrates Life Sciences Metabolomics Biomarker Product
Table 64. Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 65. Biocrates Life Sciences Recent Development
Table 66. Biomark Diagnostics Company Details
Table 67. Biomark Diagnostics Business Overview
Table 68. Biomark Diagnostics Metabolomics Biomarker Product
Table 69. Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 70. Biomark Diagnostics Recent Development
Table 71. Chenomx Company Details
Table 72. Chenomx Business Overview
Table 73. Chenomx Metabolomics Biomarker Product
Table 74. Chenomx Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 75. Chenomx Recent Development
Table 76. Creative Proteomics Company Details
Table 77. Creative Proteomics Business Overview
Table 78. Creative Proteomics Metabolomics Biomarker Product
Table 79. Creative Proteomics Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 80. Creative Proteomics Recent Development
Table 81. Evotec Company Details
Table 82. Evotec Business Overview
Table 83. Evotec Metabolomics Biomarker Product
Table 84. Evotec Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 85. Evotec Recent Development
Table 86. Human Metabolome Technologies Company Details
Table 87. Human Metabolome Technologies Business Overview
Table 88. Human Metabolome Technologies Metabolomics Biomarker Product
Table 89. Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 90. Human Metabolome Technologies Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Metabolomics Biomarker Product
Table 94. Merck Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Metabolomic Diagnostics Company Details
Table 97. Metabolomic Diagnostics Business Overview
Table 98. Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 99. Metabolomic Diagnostics Recent Development
Table 100. Metabolon Company Details
Table 101. Metabolon Business Overview
Table 102. Metabolon Metabolomics Biomarker Product
Table 103. Metabolon Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 104. Metabolon Recent Development
Table 105. Ovid Therapeutics Company Details
Table 106. Ovid Therapeutics Business Overview
Table 107. Ovid Therapeutics Metabolomics Biomarker Product
Table 108. Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2016-2021) & (US$ Million)
Table 109. Ovid Therapeutics Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolomics Biomarker Market Share by Type: 2020 VS 2027
Figure 2. Protein Marker Features
Figure 3. Nucleic Acid Marker Features
Figure 4. Global Metabolomics Biomarker Market Share by Application: 2020 VS 2027
Figure 5. Toxicological studies Case Studies
Figure 6. Drug testing Case Studies
Figure 7. Cancer Case Studies
Figure 8. Cardiovascular disorders Case Studies
Figure 9. Neurological disorders Case Studies
Figure 10. Inborn errors of metabolism Case Studies
Figure 11. Metabolomics Biomarker Report Years Considered
Figure 12. Global Metabolomics Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Metabolomics Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Metabolomics Biomarker Market Share by Regions: 2020 VS 2027
Figure 15. Global Metabolomics Biomarker Market Share by Regions (2022-2027)
Figure 16. Global Metabolomics Biomarker Market Share by Players in 2020
Figure 17. Global Top Metabolomics Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolomics Biomarker as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Metabolomics Biomarker Revenue in 2020
Figure 19. Global Metabolomics Biomarker Revenue Market Share by Type (2016-2021)
Figure 20. Global Metabolomics Biomarker Revenue Market Share by Type (2022-2027)
Figure 21. North America Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Metabolomics Biomarker Market Share by Type (2016-2027)
Figure 23. North America Metabolomics Biomarker Market Share by Application (2016-2027)
Figure 24. North America Metabolomics Biomarker Market Share by Country (2016-2027)
Figure 25. United States Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Metabolomics Biomarker Market Share by Type (2016-2027)
Figure 29. Europe Metabolomics Biomarker Market Share by Application (2016-2027)
Figure 30. Europe Metabolomics Biomarker Market Share by Country (2016-2027)
Figure 31. Germany Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Metabolomics Biomarker Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Metabolomics Biomarker Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Metabolomics Biomarker Market Share by Region (2016-2027)
Figure 41. China Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Metabolomics Biomarker Market Share by Type (2016-2027)
Figure 49. Latin America Metabolomics Biomarker Market Share by Application (2016-2027)
Figure 50. Latin America Metabolomics Biomarker Market Share by Country (2016-2027)
Figure 51. Mexico Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Metabolomics Biomarker Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Metabolomics Biomarker Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Metabolomics Biomarker Market Share by Country (2016-2027)
Figure 57. Turkey Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Metabolomics Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Biocrates Life Sciences Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 61. Biomark Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 62. Chenomx Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 63. Creative Proteomics Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 64. Evotec Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 65. Human Metabolome Technologies Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 67. Metabolomic Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 68. Metabolon Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 69. Ovid Therapeutics Revenue Growth Rate in Metabolomics Biomarker Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---